BioNxt Solutions Inc.
BNXTF
$0.3747
$0.0257.15%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -4.77M | -4.74M | -5.78M | -5.72M | -9.33M |
| Total Depreciation and Amortization | 82.40K | 101.60K | 125.80K | 145.20K | 145.40K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | 4.90K |
| Total Other Non-Cash Items | 1.07M | 987.60K | 1.45M | 1.39M | 5.22M |
| Change in Net Operating Assets | 1.22M | 624.80K | 815.10K | 353.30K | 41.50K |
| Cash from Operations | -2.39M | -3.02M | -3.39M | -3.83M | -3.91M |
| Capital Expenditure | -62.00K | -62.00K | -148.00K | -149.20K | -87.20K |
| Sale of Property, Plant, and Equipment | 263.30K | 263.30K | 222.20K | 222.20K | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 201.30K | 201.30K | 74.20K | 73.00K | -87.20K |
| Total Debt Issued | -- | -- | -- | -- | 2.58M |
| Total Debt Repaid | -9.30K | -18.50K | -238.30K | -247.50K | -3.47M |
| Issuance of Common Stock | 2.66M | 4.11M | 3.17M | 5.99M | 5.05M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -198.50K | -315.10K | -271.90K | -448.30K | -354.40K |
| Cash from Financing | 1.80M | 2.79M | 1.97M | 3.92M | 2.82M |
| Foreign Exchange rate Adjustments | 2.80K | 900.00 | -1.10K | 500.00 | 2.10K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -384.30K | -28.10K | -1.34M | 162.90K | -1.18M |
